Clinical Trials Directory

Trials / Completed

CompletedNCT01381081

Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis

A Prospective, Randomized, Double-blinded, Clinical Trial, Comparing Platelet-rich Plasma Intra-articular Knee Injections Versus Corticosteroid Intra-articular Knee Injections for Knee Osteoarthritis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The benefit of using platelet rich plasma (PRP) in cartilage injuries, and specifically in degenerative ones, has not been assessed yet. Current studies on the PRP healing or repairing effect on knee cartilage degenerative injuries are not conclusive to establish a standard of behavior, although PRP has shown to improve joint functionality and reduce pain. Hypothesis: PRP intra-articular injections in osteoarthritic knees reduces pain and leads to a more effective and lasting functional recovering than corticosteroid intra-articular injections.

Conditions

Interventions

TypeNameDescription
BIOLOGICALplatelet-rich plasmaa single intra-articular injection
DRUGCorticosteroidA single betamethasone and bupivacaine intra-articular injection

Timeline

Start date
2011-07-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2011-06-27
Last updated
2015-02-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01381081. Inclusion in this directory is not an endorsement.